Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020187945> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2020187945 endingPage "245" @default.
- W2020187945 startingPage "241" @default.
- W2020187945 abstract "In some patients with Graves' disease, ophthalmopathy develops or deteriorates after initiation of therapy for hyperthyroidism. The possible relationship between the management of hyperthyroidism and the course of ophthalmopathy has been addressed in several studies but with conflicting results. The overall impression, when comparing these studies, is that there is no definite difference between the three forms of therapy for hyperthyroidism with regard to the course of ophthalmopathy, although there are more studies suggesting that 131I carries a higher risk for aggravating the eye disease. However, many of these studies are retrospective, contain few patients, have a short follow-up time, and include patients who have received more than one type of treatment. We performed a prospective study in which patients were randomized to either antithyroid drugs, subtotal thyroidectomy, or 131I. We found that 33% of the patients treated with 131i deteriorated compared with 10% and 16% of patients treated with antithyroid drugs and surgery, respectively (p = 0.02). The risk was greater when patients had very high pretreatment thyroid hormone levels. On the other hand, patients treated with 131I were given thyroxine later than the other patients, although this fact did not appear to be of importance for the results. In another retrospective study, we showed that early administration with thyroxine can reduce the risk for ophthalmopathy, and we now are undertaking a prospective study in which treatment with antithyroid drugs is compared with 131I treatment and early thyroxine. Our guidelines for ablative therapy in patients with progressive ophthalmopathy are presented." @default.
- W2020187945 created "2016-06-24" @default.
- W2020187945 creator A5022593811 @default.
- W2020187945 creator A5026734949 @default.
- W2020187945 date "1997-04-01" @default.
- W2020187945 modified "2023-10-17" @default.
- W2020187945 title "Radioiodine Treatment, Ablation, and Ophthalmopathy: A Balanced Perspective" @default.
- W2020187945 cites W1492274730 @default.
- W2020187945 cites W1966641441 @default.
- W2020187945 cites W1984403151 @default.
- W2020187945 cites W2028309686 @default.
- W2020187945 cites W2029891090 @default.
- W2020187945 cites W2030081646 @default.
- W2020187945 cites W2043565912 @default.
- W2020187945 cites W2044012428 @default.
- W2020187945 cites W2077327610 @default.
- W2020187945 cites W2077973993 @default.
- W2020187945 cites W2135506321 @default.
- W2020187945 cites W2153640804 @default.
- W2020187945 cites W4244720062 @default.
- W2020187945 cites W4248945167 @default.
- W2020187945 doi "https://doi.org/10.1089/thy.1997.7.241" @default.
- W2020187945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9133694" @default.
- W2020187945 hasPublicationYear "1997" @default.
- W2020187945 type Work @default.
- W2020187945 sameAs 2020187945 @default.
- W2020187945 citedByCount "46" @default.
- W2020187945 countsByYear W20201879452012 @default.
- W2020187945 countsByYear W20201879452014 @default.
- W2020187945 countsByYear W20201879452015 @default.
- W2020187945 countsByYear W20201879452016 @default.
- W2020187945 countsByYear W20201879452019 @default.
- W2020187945 countsByYear W20201879452021 @default.
- W2020187945 countsByYear W20201879452022 @default.
- W2020187945 crossrefType "journal-article" @default.
- W2020187945 hasAuthorship W2020187945A5022593811 @default.
- W2020187945 hasAuthorship W2020187945A5026734949 @default.
- W2020187945 hasConcept C126322002 @default.
- W2020187945 hasConcept C141071460 @default.
- W2020187945 hasConcept C167135981 @default.
- W2020187945 hasConcept C188816634 @default.
- W2020187945 hasConcept C2776606491 @default.
- W2020187945 hasConcept C2776652619 @default.
- W2020187945 hasConcept C2776685619 @default.
- W2020187945 hasConcept C2777074255 @default.
- W2020187945 hasConcept C2778902805 @default.
- W2020187945 hasConcept C2779134260 @default.
- W2020187945 hasConcept C2909564963 @default.
- W2020187945 hasConcept C526584372 @default.
- W2020187945 hasConcept C71924100 @default.
- W2020187945 hasConceptScore W2020187945C126322002 @default.
- W2020187945 hasConceptScore W2020187945C141071460 @default.
- W2020187945 hasConceptScore W2020187945C167135981 @default.
- W2020187945 hasConceptScore W2020187945C188816634 @default.
- W2020187945 hasConceptScore W2020187945C2776606491 @default.
- W2020187945 hasConceptScore W2020187945C2776652619 @default.
- W2020187945 hasConceptScore W2020187945C2776685619 @default.
- W2020187945 hasConceptScore W2020187945C2777074255 @default.
- W2020187945 hasConceptScore W2020187945C2778902805 @default.
- W2020187945 hasConceptScore W2020187945C2779134260 @default.
- W2020187945 hasConceptScore W2020187945C2909564963 @default.
- W2020187945 hasConceptScore W2020187945C526584372 @default.
- W2020187945 hasConceptScore W2020187945C71924100 @default.
- W2020187945 hasIssue "2" @default.
- W2020187945 hasLocation W20201879451 @default.
- W2020187945 hasLocation W20201879452 @default.
- W2020187945 hasOpenAccess W2020187945 @default.
- W2020187945 hasPrimaryLocation W20201879451 @default.
- W2020187945 hasRelatedWork W122268571 @default.
- W2020187945 hasRelatedWork W2034571916 @default.
- W2020187945 hasRelatedWork W2072338241 @default.
- W2020187945 hasRelatedWork W2107212456 @default.
- W2020187945 hasRelatedWork W2371608734 @default.
- W2020187945 hasRelatedWork W2409224349 @default.
- W2020187945 hasRelatedWork W2412222815 @default.
- W2020187945 hasRelatedWork W2419168948 @default.
- W2020187945 hasRelatedWork W2808755834 @default.
- W2020187945 hasRelatedWork W2182467391 @default.
- W2020187945 hasVolume "7" @default.
- W2020187945 isParatext "false" @default.
- W2020187945 isRetracted "false" @default.
- W2020187945 magId "2020187945" @default.
- W2020187945 workType "article" @default.